According to one of the authors, additional work is needed to validate findings in a larger prospective study ‘and to apply ...
New hope for advanced prostate cancer patients, with promising new drug combo that targets genes, such as BRCA1, BRCA2, CHEK2 ...
MedPage Today on MSN
Evolocumab Reduced First CV Events in Patients Without Prior MI or Stroke
NEW ORLEANS -- Adding the PCSK9 inhibitor evolocumab (Repatha) to stable lipid-lowering therapy reduced major adverse cardiac ...
News Medical on MSN
Capturing cancer cells from blood could help doctors choose the right breast cancer treatment
Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer ...
Nuvalent is approaching the precipice of a first targeted therapy approval in lung cancer. Click here to read why NUVL stock ...
Compassus Health and Hospice Care consultant Kathy Rackers gave insight into end-of-life care to the Callaway Resource ...
News Medical on MSN
New USC study identifies key genes linked to aggressive prostate cancer in people of African descent
New prostate cancer research from an international team led by the Center for Genetic Epidemiology at the Keck School of Medicine of USC has yielded discoveries that could improve screening and ...
New research from Moffitt Cancer Center shows that RAS(ON) multi-selective inhibition can directly block tumor growth and ...
Aggressive driving is a cousin to road rage but not the same because it comes down to intent. “Aggressive can be just common ...
KFSHRC has achieved a major breakthrough in precision medicine by successfully treating its first patient with locally ...
More than 28% of lung cancers were detected early, when survival rates are better — a 12% improvement over five years. Also, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results